Johnson Investment Counsel Inc Bluebird Bio, Inc. Transaction History

Johnson Investment Counsel Inc

  • $10.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024
SELL
$0.91 - $1.75 $3,782 - $7,274
-4,157 Reduced 14.91%
23,732 $30,000
Q4 2023

Feb 07, 2024
BUY
$1.32 - $4.83 $19,377 - $70,904
14,680 Added 111.14%
27,889 $38,000
Q3 2023

Nov 13, 2023
BUY
$3.02 - $4.05 $39,891 - $53,496
13,209 New
13,209 $40,000

Others Institutions Holding BLUE

# of Institutions
150
Shares Held
63.4M
Call Options Held
264K
Put Options Held
428K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $708M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Johnson Investment Counsel Inc Portfolio

Follow Johnson Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email